Startups
Incendia Therapeutics
Develops monoclonal antibody therapies designed to disrupt barriers in the tumor microenvironment. Its research targets structural and biochemical mechanisms that keep immune cells out of tumors, with the aim of improving the activity of cancer immunotherapies.
Team
Antoine ItalianoCompany Advisor |
Bradford SmithCompany Advisor and Former CFO |
Brian KiralyActing Head of Finance |
 Christopher O’DonnellBoard Director |
Hervé FridmanCompany Advisor |
John M. GoldbergActing Chief Development Officer |
Joseph Paul EderChief Medical Officer (in memoriam, 2026) |
Mace RothenbergCompany Advisor |
Michael CecchiniCompany Advisor |
Michael KauffmanChairman of the Board |
Pamela MunsterCompany Advisor |
Paolo ProvenzanoCompany Advisor |
Sakae AsanumaBoard Director |
Scott L. FriedmanCompany Advisor |
 Steve LiapisBoard Director |
Susan G. MacdonaldSVP, Non Clinical Development & Strategy |
Thomas SchürpfSVP, Research |
Wendye R. RobbinsPresident, CEO and Board Director |